Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI

Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI

ObjectivesTo compare definitions of high disease activity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in selecting patients for treatment with biologic disease-modifying antirheumatic drugs (bDMARDs).MethodsPatients fro...

Full description

Bibliographic Details
Main Authors: Sofia Ramiro, Alexandre Sepriano, Jose Marona, Santiago Rodrigues-Manica, Fernando Pimentel-Santos, Ana Filipa Mourão, Nélia Gouveia, Jaime Cunha Branco, Filipe Vinagre, João Tavares-Costa, João Rovisco, Miguel Bernardes, Nathalie Madeira, Rita Cruz-Machado, Raquel Roque, Joana Leite Silva, Mary Lucy Marques, Raquel Miriam Ferreira
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/6/1/e001145.full

Internet

https://rmdopen.bmj.com/content/6/1/e001145.full

Similar Items